References

GORE® PROPATEN® Vascular Graft overall weighted primary patency

Kaisar J, Chen A, Cheung M, Kfoury E, Bechara C, Lin P. Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass. Vascular 2018;26(2):117-125.

Piffaretti G, Dorigo W, Castelli P, Pratesi C, Pulli R. PROPATEN Italian Registry Group. Results from a multicenter registry of heparinbonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass. Journal of Vascular Surgery 2018;67(5):1463-1471.e1.

Samson RH, Morales R, Showalter DP, Lepore MR, Nair DG. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison. Journal of Vascular Surgery 2016;64(3):638-647.

Uhl C, Hock C, Betz T, Greindl M, Töpel I, Steinbauer M. Comparison of venous and HePTFE tibial and peroneal bypasses in critical limb ischemia patients unsuitable for endovascular revascularization. Vascular 2015;23(6):607-613.

Neville RF, Babrowicz J, Amdur R, Sidawy A. Heparin-bonded ePTFE (Propaten): is it as good as autologous vein for tibial bypass? Italian Journal of Vascular & Endovascular Surgery 2014;21(1)49-56.

Monaca V, Battaglia G, Turiano SA, Tringale R, Catalfamo S. Subpopliteal revascularization. Criteria analysis for use of E-PTFE (Propaten®) as first choice conduit. Italian Journal of Vascular & Endovascular Surgery 2013;20(3):165-169.

Dorigo W, Raffaele P, Piffaretti G. Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses. Journal of Cardiovascular Surgery 2012;53(2):187-193.

B, Johannesen N, et al. The Scandinavian Propaten® trial – 1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses – a randomised clinical controlled multi-centre trial. European Journal of Vascular & Endovascular Surgery 2011;41(5):668-673.

Pulli R, Dorigo W, Castelli P, et al. Propaten Italian Registry Group. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. Journal of Vascular Surgery 2010;51(5):1167-1177.e1.

Daenens K, Schepers S, Fourneau I, Houthoofd S, Nevelsteen A. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. Journal of Vascular Surgery 2009;49(5):1210-1216.

Hugl B, Nevelsteen A, Daenens K, et al. PEPE II Study Group. PEPE II - a multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below knee bypass surgery: determinants of patency. Journal of Cardiovascular Surgery 2009;50(2):195-203.

Lösel-Sadée H, Alefelder C. Heparin-bonded expanded polytetrafluoroethylene graft for infragenicular bypass: five-year results. Journal of Cardiovascular Surgery 2009;50(3):339-343.

Peeters P, Verbist J, Deloose K, Bosiers M. Will heparin-bonded PTFE replace autologous venous conduits in infrapopliteal bypass? Italian Journal of Vascular & Endovascular Surgery 2008;15(3):143-148.

Bosiers M, Deloose K, Verbist J, et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. Journal of Vascular Surgery 2006;43(2):313-319.

GORE® PROPATEN® Vascular Graft clinical performance

Inclusion criteria are clinical journal articles in English language, with non-overlapping patient populations, and 50 or more below knee bypasses with GORE® PROPATEN® Vascular Graft.

Kaisar J, Chen A, Cheung M, Kfoury E, Bechara CF, Lin PH. Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass. Vascular 2018;26(2):117-125.

Uhl C, Grosch C, Hock C, Töpel I, Steinbauer M. Comparison of long-term outcomes of heparin bonded polytetrafluoroethylene and autologous vein below knee femoropopliteal bypasses in patients with critical limb ischaemia. European Journal of Vascular & Endovascular Surgery 2017;54(2):203-211.

Uhl C, Hock C, Betz T, Greindl M, Töpel I, Steinbauer M. Comparison of venous and HePTFE tibial and peroneal bypasses in critical limb ischemia patients unsuitable for endovascular revascularization. Vascular 2015;23(6):607-613.

Neville RF, Babrowicz J, Amdur R, Sidawy A. Heparin-bonded ePTFE (Propaten): is it as good as autologous vein for tibial bypass? Italian Journal of Vascular & Endovascular Surgery 2014;21(1)49-56.

Monaca V, Battaglia G, Turiano SA, Tringale R, Catalfamo S. Sub popliteal revascularization. Criteria analysis for use of E-PTFE (Propaten®) as first choice conduit. Italian Journal of Vascular & Endovascular Surgery 2013;20(3):165-169.

Pulli R, Dorigo W, Castelli P, et al; Propaten Italian Registry Group. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. Journal of Vascular Surgery 2010;51(5):1167-1177.e1.

Hugl B, Nevelsteen A, Daenens K, et al; PEPE II Study Group. PEPE II – a multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below knee bypass surgery: determinants of patency. Journal of Cardiovascular Surgery 2009;50(2):195-203.

Lösel-Sadée H, Alefelder C. Heparin-bonded expanded polytetrafluoroethylene graft for infragenicular bypass: five-year results. Journal of Cardiovascular Surgery 2009;50(3):339-343.

Peeters P, Verbist J, Deloose K, Bosiers M. Will heparin-bonded PTFE replace autologous venous conduits in infrapopliteal bypass? Italian Journal of Vascular & Endovascular Surgery 2008;15(3):143-148.

Standard ePTFE clinical performance

Inclusion criteria are clinical journal articles in English language, with non-overlapping patient populations, and 50 or more below knee bypasses with standard ePTFE.

van der Slegt J, Steunenberg SL, Donker JM, et al. The current position of precuffed expanded polytetrafluoroethylene bypass grafts in peripheral vascular surgery. Journal of Vascular Surgery 2014;60(1):120-128.

Loh SA, Howell BS, Rockman CB, et al. Mid- and long-term results of the treatment of infrainguinal arterial occlusive disease with precuffed expanded polytetrafluoroethylene grafts compared with vein grafts. Annals of Vascular Surgery 2013;27(2):208-217.

Lundgren F; Swedish External Support Study (SWEXSUS). External support of a polytetrafluoroethylene graft improves patency for bypass to below-knee arteries. Annals of Vascular Surgery 2013;27(8):1124-1133.

Oberhuber A, Benecke B, Orend KH, Hutschenreiter S, Muehling BM. The diabetic patient has a higher benefit from infrapopliteal revascularization than the non-diabetic patient: a 10-year retrospective study. Diabetes & Vascular Disease Research 2013;10(1):78-83.

Donker JM, Ho GH, Te Slaa A, et al. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease. Vascular & Endovascular Surgery 2011;45(7):598-603.

SCAMICOS. PTFE bypass to below-knee arteries: distal vein collar or not? A prospective randomised multicentre study. European Journal of Vascular & Endovascular Surgery 2010;39(6):747-754.

Gulkarov I, Malik R, Yakubov R, et al. Early results for below-knee bypasses using Distaflo. Vascular & Endovascular Surgery 2008/2009;42(6):561-566.

Brumberg RS, Back MR, Armstrong PA, et al. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. Journal of Vascular Surgery 2007;46(6):1160-1166.

Kapfer X, Meichelboeck W, Groegler F-M. Comparison of carbon-impregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: a prospective randomized multicenter study. European Journal of Vascular & Endovascular Surgery 2006;32(2):155-168.

Aracil-Sanus E, Mendieta-Azcona C, Cuesta-Gimeno C, Chinchilla-Molina A. Infragenicular bypass graft for limb salvage using polytetrafluoroethylene and distal vein cuff as the first alternative in patients without ipsilateral greater saphenous vein. Annals of Vascular Surgery 2005;19(3):379-385.

Hingorani AP, Ascher E, Marks NA, et al. A 10-year experience with complementary distal arteriovenous fistula and deep vein interposition for infrapopliteal prosthetic bypasses. Vascular & Endovascular Surgery 2005;39(5):401-409.

Oderich GS, Panneton JM, Yagubyan M, et al. Comparison of precuffed and vein-cuffed expanded polytetrafluoroethylene grafts for infragenicular arterial reconstructions: a case-matched study. Annals of Vascular Surgery 2005;19(1):49-55.

Ducasse E, Chevalier J, Chevier E, et al. Patency and limb salvage after distal prosthetic bypass associated with vein cuff and arteriovenous fistula. European Journal of Vascular & Endovascular Surgery 2004;27(4):417-422.

Grego F, Antonello M, Stramana R, Deriu GP, Lepidi S. Popliteal-to-distal bypass for limb salvage. Annals of Vascular Surgery 2004;18(3):321-328.

Kersting S, Ockert D, Zimmermann T, Meichelböck W, Saeger HD, Bergert H. Infragenicular polytetrafluoroethylene bypass with tapered versus straight vascular grafts: results from a prospective multicenter cohort study. Annals of Vascular Surgery 2004;18(4):440-447.

Laurila K, Lepäntalo M, Teittinen K, et al. Does an adjuvant AV-fistula improve the patency of a femorocrural PTFE bypass with distal vein cuff in critical leg ischaemia? A prospective randomised multicentre trial. European Journal of Vascular & Endovascular Surgery 2004;27(2):180-185.

Panneton JM, Hollier LH, Hofer JM. Multicenter randomized prospective trial comparing a pre-cuffed polytetrafluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass. Annals of Vascular Surgery 2004;18(2):199-206.

 

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.